Trump's Maha Health Agenda Stalls as Key CDC and Surgeon General Roles Remain Vacant
The Trump administration's "Make America healthy again" (Maha) agenda is encountering significant delays, with two of the most influential public health positions in the United States government currently unfilled. President Trump has not yet nominated a permanent director for the Centers for Disease Control and Prevention (CDC), leaving the agency without stable leadership for over 210 days, which exceeds the legal limit for an acting head. Simultaneously, the nomination of Casey Means for surgeon general is stalled in the Senate, creating further uncertainty in the nation's health governance.
Leadership Void at the CDC
The CDC has been operating without a Senate-confirmed director since July, when the last confirmed director, Susan Monarez, was fired after clashing with Health Secretary Robert F Kennedy Jr over vaccine policies. Since then, the agency has experienced a departure of senior public health officials, many of whom accused Kennedy of politicizing the CDC and undermining its independence. This turmoil was exacerbated by a shooting at the CDC headquarters in Atlanta, where a gunman, blaming Covid vaccines for his mental health issues, killed a police officer.
Currently, Jay Bhattacharya, who also leads the National Institutes of Health (NIH), is serving as the interim chief of the CDC. He is expected to continue in this role through a delegation of authority from Health Secretary Kennedy, according to statements from the Department of Health and Human Services (HHS) and the White House. The HHS has stated that Kennedy and Chris Klomp, director of Medicare and deputy administrator of the Centers for Medicare and Medicaid Services (CMS), are collaborating with the White House to evaluate candidates for the CDC director position who align with the administration's goal of refocusing the agency on combating infectious diseases.
Impact on Vaccine Recommendations
The absence of a permanent CDC director has significant implications for vaccine policy. Under federal law, only the CDC director can formally approve recommendations from the Advisory Committee on Immunization Practices (ACIP). With the position vacant, this authority effectively shifts to Health Secretary Kennedy. This shift comes amid recent legal challenges; a federal judge ruled earlier this month that Kennedy's handpicked vaccine advisory panel was unlawfully appointed, voiding many of their decisions, including those on flu, Covid, and RSV vaccines for infants.
According to Stanford law professor Anne Joseph O'Connell, the lack of a confirmed director complicates the approval process for vaccine recommendations, potentially delaying public health initiatives. The New York Times reported that the Trump administration is struggling to find a nominee who both aligns with its mission and can secure Senate confirmation, highlighting the political hurdles involved.
Surgeon General Nomination in Limbo
Casey Means, Trump's nominee for surgeon general, has faced prolonged delays in her confirmation process. Nominated over 320 days ago, Means testified before the Senate health committee more than a month ago, but a vote has yet to be scheduled. Her initial hearing was postponed when she went into labor hours before it was set to occur. Means, 38, is not a board-certified doctor and does not hold an active medical license; she graduated from Stanford School of Medicine but did not complete her surgical residency. Her background primarily involves work as a wellness influencer and leadership within the Maha movement.
During her confirmation hearing, Means evaded questions on vaccine guidance, argued that chronic health issues stem from lifestyle and environmental factors, and faced scrutiny over potential conflicts of interest related to her social media promotions of wellness products. Key Republican senators on the health committee, including Bill Cassidy of Louisiana, Susan Collins of Maine, and Lisa Murkowski of Alaska, have expressed skepticism about her qualifications and public health perspectives. Collins and Murkowski have stated they are undecided on their votes, with Murkowski noting concerns about unkept assurances on vaccines from Health Secretary Kennedy.
Political Pressure and Future Prospects
Allies of the Maha movement are applying pressure to secure Means's confirmation. During a weekly call with the advocacy group Maha Action, Republican senator Rand Paul urged attendees to contact Cassidy, Collins, and Murkowski to support Means. Paul emphasized that the nomination should have been voted on already and criticized the lack of vocal support from these senators. He added that if Means cannot gain the necessary support, opponents should be publicly recorded as such.
The ongoing vacancies and nomination delays underscore the challenges in advancing the Trump administration's health agenda. With both the CDC and surgeon general positions in flux, public health leadership remains uncertain, potentially affecting national responses to health crises and vaccine policies. As the White House continues its search for a CDC director and navigates the Senate confirmation process for Means, the Maha agenda's progress hinges on resolving these leadership gaps.
